Clinical Trials Sponsored by ASQA a.s.

Total 1952 results

ASQA a.s.

Unknown

Lithium Dilution Method in Guiding Fluid Therapy in Critically Ill Patients (LIGA)

Critical Illness

Czech Republic
Nykode Therapeutics ASA
Vaccibody AS

Completed

A Phase 1/2 Study to Determine Safety and Immunogenicity of Two COVID 19 Vaccines VB10.2129 (RBD Candidate) and VB10.2210 (T Cell Candidate) Previously Vaccinated in Healthy Adult Volunteers

Infections | COVID-19 | Infection Viral

Norway
Bioster, a.s.

Completed

Traumacel PULVIS and Traumacel ENDO Applicator in the Post-market Surveillance Phase

Bleeding | Surgical Wound

Czechia
Mabpro, a.s.

Not yet recruiting

Clinical Study to Evaluate Safety and Dosing of CA9hu-1 in Patients With Advanced Solid Tumours (CAMP1)

Head and Neck Cancer | Mesothelioma, Malignant | TNBC - Triple-Negative Breast Cancer | Non-small-cell Lung Carcinoma | Clear Cell Renal Cell Carcinoma Metastatic
Bioster, a.s.

Completed

Traumacel FAM Trium in the Post-market Surveillance Phase

Bleeding | Surgical Wound

Czechia
Nykode Therapeutics ASA
Theradex; Vaccibody AS

Completed

An Exploratory Safety and Immunogenicity Study of HPV16+ Immunotherapy VB10.16 in Women With HSIL; CIN 2/3)

High Grade Cervical Intraepithelial Neoplasia

Germany
Contipro Pharma a.s.

Recruiting

Multi-centre, Open-label, First-in-man Study With Mucopad HA

Oral Mucositis

Czechia
Contipro Pharma a.s.

Completed

Multi-centre, Open-label, First-in-man Study With Epipad Used in Adult Patients

Wound

Czechia
Contipro Pharma a.s.

Completed

Study With Fascigel

Back Pain

Czechia
Contipro Pharma a.s.

Completed

First-in-man Study of Adult Patients Suffered From Alveolar Osteitis Treated Using Stomatological Tamponade Contipro

Alveolar Osteitis

Czechia
Nykode Therapeutics ASA
Nektar Therapeutics; Vaccibody AS

Completed

A Study to Evaluate Safety and Efficacy of Multiple Dosing With VB10.NEO and Bempegaldesleukin (NKTR-214) Immunotherapy in Patients With Locally Advanced or Metastatic Cancer (DIRECT-01)

Locally Advanced or Metastatic Solid Tumours

Germany
Aspa Therapeutics

Recruiting

Natural History Study of Patients With Canavan Disease

Canavan Disease

United States, Germany
Columbia Asia

Completed

Effect of Wearing of White Coat on Patient Satisfaction in Indian Out Patient Department (OPD) Setting

Patient Compliance | Physician-Patient Relations

India
Nykode Therapeutics ASA
Genentech, Inc.; Vaccibody AS

Active, not recruiting

Study of VB10.NEO in Combination With Atezolizumab in Solid Tumors

Solid Tumors, Adult

Spain, United States, Germany
Asia University

Not yet recruiting

Effectiveness of Recruitment Maneuvers and Lung Protective Ventilation Strategy in ARDS (ARDS)

ARDS

Taiwan
Aspa Therapeutics

Recruiting

A Study of AAV9 Gene Therapy in Participants With Canavan Disease (CANaspire)

Canavan Disease

United States
Asia University

Active, not recruiting

Effects of Acupressure at Sanyinjiao Point on Primary Dysmenorrhea Among University Students.

Primary Dysmenorrhea | Acupuncture

Taiwan
Asia University

Completed

A Caregiver-mediated Health Educational Intervention to Improve Constipation Status of Primary School Children

Constipation

Taiwan
Asia University

Active, not recruiting

Protein Supplementation Intervention for Improving Muscle Mass and Physical Performance in Older People With Sarcopenia

Sarcopenia

Taiwan
Asia University

Completed

A Need-based Nutritional Intervention in Nursing Home Residents

Malnutrition

Taiwan
Columbia Asia

Unknown

Hair Fall in Patients on Low Dose Methotrexate

Rheumatoid Arthritis | Alopecia | Methotrexate Adverse Reaction

India
Tesu Saglik Teknolojileri A.S.

Recruiting

Efficacy and Safety of Digital Therapeutic in Adults With Prediabetes

PreDiabetes

Turkey
SOTIO a.s.

Completed

Evaluation of Safety and Efficacy of DCVAC/LuCa (Immunotherapy of Lung Cancer) in Patients With Metastatic Lung Cancer

Stage IV Non-small Cell Lung Cancer

Czechia, Slovakia
SOTIO a.s.

Completed

DCVAC/OvCa After Standard-of-care Chemotherapy in Women With Relapse of Platinum-sensitive Epithelial Ovarian Cancer

Ovarian Cancer Recurrent

Czechia
SOTIO a.s.

Completed

Phase II Study DCVAC/OvCa Added to First Line Carboplatin and Paclitaxel Newly Diagnosed Epithelial Ovarian Carcinoma

Ovarian Neoplasms | Ovarian Epithelial Cancer

Czechia, Poland
SOTIO a.s.

Completed

Phase II Study DCVAC/OvCa Plus Carboplatin Gemcitabine Relapsed Platinum (Pt)-Sensitive Epithelial Ovarian Carcinoma

Ovarian Neoplasms | Ovarian Epithelial Cancer | Ovarian Cancer (OvCa)

Czechia, Poland, Germany
SOTIO a.s.

Completed

Phase II Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer

Prostate Cancer | Prostate Cancer Metastatic

Czechia
SOTIO a.s.

Completed

Phase II Study of DCVAC/PCa Added to Hormone Therapy for Men With Metastatic Prostate Cancer

Prostate Cancer

Czechia
SOTIO a.s.

Completed

Phase III Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer (VIABLE)

Metastatic Castration-resistant Prostate Cancer

United States, Spain, United Kingdom, Germany, Serbia, Portugal, Lithuania, Slovakia, Hungary, Netherlands, Croatia, France, Czechia, Poland, Austria, Belarus, Belgium, Bulgaria, Denmark, Italy, Latvia, Sweden
SOTIO a.s.

Terminated

A Phase I/II, Safety Clinical Trial of DCVAC/PCa and ONCOS-102 in Men With Metastatic Castration-resistant Prostate Cancer

Castration-resistant Prostate Cancer

Czechia
SOTIO a.s.

Completed

Phase II Study of DCVAC/PCa After Primary Radiotherapy for Patients With High Risk Localized Prostate Cancer

Prostate Cancer

Czechia
SOTIO a.s.

Completed

Phase II Study of DCVAC/PCa Added After Radical Primary Prostatectomy for Patients With Localized Prostate Cancer

Prostate Cancer

Czechia
SOTIO a.s.

Completed

Study to Allow for Second Treatment Cycle of DCVAC in Patients With Localized Prostate Cancer

Prostate Cancer

Czechia
SOTIO a.s.

Terminated

Efficacy of DCVAC/OvCa Plus Standard of Care in Relapsed Platinum Resistant Epithelial Ovarian Carcinoma

Epithelial Ovarian Carcinoma

Germany, Poland, Czech Republic
Nykode Therapeutics ASA
Roche Pharma AG; Vaccibody AS

Completed

Investigating the Combination of VB10.16 and Atezolizumab in Patients With HPV 16-positive Cervical Cancer

Cervical Cancer | Cervix Cancer

Belgium, Germany, Bulgaria, Czechia, Norway, Poland
Asia Diabetes Foundation

Completed

Effectiveness of a Treat-to-target Clinic Led by a Nurse Consultants

Diabetes

Hong Kong
Asia Diabetes Foundation

Completed

PLATINUM Program: A Feasibility Study on a Train-the-trainer Course on Peer Support for People With Type 2 Diabetes (PLATINUM)

Diabetes

Hong Kong
Asia Diabetes Foundation

Completed

Using a Diabetic Kidney Disease (DKD) Registry to Treat to Multiple Targets (TMT) (DKD-TMT)

Diabetic Kidney Disease

Taiwan, China, Hong Kong, Korea, Republic of, Malaysia, Thailand, Vietnam
Asia Diabetes Foundation

Completed

Establishing a Diabetes Registry Using the JADE-DIAMOND Electronic Portal (CN001) (China-JD)

Diabetes

Hong Kong
Asia Diabetes Foundation

Completed

Comparing the Effect of Structured Care Versus Usual Care in Type 2 Diabetes Patients Across the Asia Pacific Region (AP-JD)

Diabetes

Hong Kong
Asia Diabetes Foundation

Unknown

Evaluation of Morbidities, Endpoints and Reaching Targets in Diabetic Patients Managed by a Diabetes Specialist Team (EMERALD)

Obesity | Diabetes

Hong Kong
Asia Diabetes Foundation

Unknown

An Evaluation of the Effectiveness and Acceptability of Delivering Structured Care in Chinese Type 2 Diabetic Patients (JADE-JA)

Diabetes

China
Contact Asia Pacific

Unknown

Observation Only Study Involving Participants Enrolled in the CHAT Trial

Breast Cancer

Australia
Masaryk Hospital Krajská zdravotní a.s.

Completed

Estimation of Coagulation Factor XIII Activity Based on the Initial Plasma Fibrinogen Level in Trauma

Coagulation Disorder | Multiple Trauma | Coagulation Defect; Acquired | Coagulation Factor Deficiency

Czechia
Medistim ASA

Not yet recruiting

Peripheral Bypass Trial for Completion Control (PATENT)

Chronic Limb-Threatening Ischemia
BerGenBio ASA

Recruiting

A Study to Investigate the Safety, Tolerability, and Preliminary Anti-tumor Activity of Bemcentinib in Combination With Pembrolizumab Plus Pemetrexed and Carboplatin in Adult Participants With Untreated Non-squamous Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States
BerGenBio ASA

Terminated

A Study of Tilvestamab (BGB149) in Relapsed, Platinum-resistant, High-grade Serous Ovarian Cancer (HGSOC) Participants

Ovarian Neoplasms

Korea, Republic of, Singapore, United Kingdom, Norway
Ultimovacs ASA

Active, not recruiting

UV1 Vaccine With Pembrolizumab for Patients With Unresectable or Metastatic Melanoma

Malignant Melanoma

United States
BerGenBio ASA

Completed

A Study of BGB324(Bemcentinib) in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
Targovax ASA

Completed

Antigen-specific Cancer Immunotherapy (TG01) and Gemcitabine as Adjuvant Therapy in Resected Pancreatic Cancer

Pancreatic Cancer, Resected

Norway, Spain, United Kingdom

3

Subscribe